Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, |
RCV001263707 | SCV001441799 | likely pathogenic | Fanconi anemia complementation group A | 2019-07-13 | criteria provided, single submitter | clinical testing | |
| Fulgent Genetics, |
RCV001263707 | SCV002788830 | likely pathogenic | Fanconi anemia complementation group A | 2021-08-10 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV003635956 | SCV004552980 | pathogenic | Fanconi anemia | 2023-10-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1167*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 983704). For these reasons, this variant has been classified as Pathogenic. |